In a significant move aimed at bolstering its market presence, Dr. Max Serbia has appointed Miloš Jauković as its new Chief Executive Officer. Mr. Jauković brings with him a wealth of experience, having spent over 25 years in senior roles within multinational corporations. His extensive expertise is expected to play a pivotal role in reinforcing the company’s position in the competitive Serbian pharmaceutical market.
Mr. Jauković is no stranger to Dr. Max, having served as the Director of Operations in 2022 and 2023. During this tenure, he familiarised himself with the company’s inner workings and its personnel, thereby positioning him uniquely to drive the company’s growth and development strategy. His appointment is anticipated to herald a new era of strategic expansion and operational excellence for Dr. Max Serbia.
